Led · Series A · Jan 2019

Neosensory develops non-invasive wearable devices that translate external information (for example, sound, light or data streams) into patterns of skin vibrations. The company’s first product, a wristband called the Buzz, is planned for release later this year. Neosensory was co-founded by neuroscientists David Eagleman and Scott Novich. The firm raised $10M in a Series A to fund product launch and growth. Investors joining the round will also gain board representation. The company focuses on sending information to the brain through touch-based interfaces.

Participated · Equity · Nov 2018

ClearDATA provides a cloud computing platform and services that enable healthcare organizations to use public clouds while ensuring ultra-secure, compliant IT environments across AWS, Google Cloud Platform, and Microsoft Azure. The company’s core offering is HITRUST-certified security and compliance tooling and a comprehensive Business Associate Agreement tailored for healthcare customers. ClearDATA’s subscription services constitute a majority of its revenue and have grown approximately 100% year-over-year since its initial funding in early 2012. With the recent $26 million financing, the company plans to expand product innovation, scale and broaden its services, and enhance customer success to support larger enterprise customers. It also intends to increase sales and marketing resources to accelerate adoption of advanced technologies such as machine learning and AI in healthcare. ClearDATA aims to help more healthcare organizations safely migrate to public clouds and improve data sharing and interoperability to drive better patient outcomes. ClearDATA provides a HIPAA-compliant managed cloud platform that safeguards patient data and powers critical healthcare applications. The company uses compliance and security safeguards, purpose-built DevOps automation, and healthcare expertise to protect sensitive healthcare information. Led by CEO Darin Brannan, ClearDATA serves more than 350,000 healthcare professionals. It offers managed cloud services tailored to healthcare compliance and security needs. The company was selected to participate in the Amazon Web Services (AWS) Public Sector Partner Network. ClearDATA intends to use new funding to expand its marketplace presence and continue product innovation. ClearDATA is a Tempe, AZ-based healthcare cloud computing company that provides cloud computing, platform and information-security services to healthcare organizations. Led by CEO Darin Brannan, the company supports more than 320,000 practitioners who use its tools to store, manage, protect and share patient health information and applications. ClearDATA closed an over-subscribed $25M Series C to fund continued growth and product launches. Backers in the round included Heritage Group, HLM Venture Partners and Flare Capital Partners alongside existing investors Norwest Venture Partners, Merck Global Health Innovation Fund and Excel Venture Management. The company intends to deploy the proceeds to accelerate expansion and bring new products to market. ClearDATA offers a healthcare-centric, HIPAA-compliant cloud and managed infrastructure service, with custom-designed storage for health data and medical images. Its end-to-end offering helps healthcare customers move applications and data to the cloud and access them over a private Internet connection, with a data model that enables locating data for required HIPAA auditing. ClearDATA positions itself as an alternative to general-purpose clouds (AWS, Azure, Rackspace) by focusing on healthcare-specific security, compliance and operational needs. Customers range from small practices and clinics to hospitals and healthcare SaaS providers. The company says it will expand its platform and move into new geographies. Operating metrics in the article note ClearDATA serves over 300,000 healthcare professionals and hosts tens of millions of health records; it recently raised $14 million in Series B funding to support growth.

Participated · Equity · Sep 2018

InfoBionic develops the MoMe® ARC platform, a third-generation virtual telemetry system for remote, wireless monitoring and diagnosis of cardiac arrhythmias. Its MoMe® ARC 4-in-1 monitor pairs a 3rd-generation remote ECG device with a Bluetooth diagnostic 6-lead sensor and offers both patch-type and wire-based sensors. The system delivers heartbeat-to-heartbeat, full-disclosure ECG data over the cloud to provide near real-time, hospital telemetry-level access for clinicians. The company recently received FDA approval for the third-generation MoMe® ARC platform. InfoBionic plans to use the Series D proceeds to continue commercial expansion of the MoMe® ARC system. The company is led by CEO Stuart Long. InfoBionic develops the MoMe® Kardia remote cardiac monitoring platform that provides physicians 24/7 on-demand access to full-disclosure Holter, Event, and MCT data via a HIPAA-compliant portal. The system is positioned to replicate in-hospital telemetry data in the outpatient setting and was granted FDA 510(k) clearance in 2015. The company targets an addressable U.S. market estimated at $1.4 billion and recently announced a commercial distribution partnership to enhance market penetration. InfoBionic reports month-to-month subscription growth rates exceeding 35% since this time last year. The completed financing is intended to support continued commercial expansion of the MoMe® Kardia system. InfoBionic develops the MoMe® Kardia system, a cloud-based remote patient monitoring platform for cardiac arrhythmia detection. The platform streams continuous electrocardiogram, respiration and motion data to the cloud for analysis and delivers automated reporting to mobile devices, tablets and web portals. It provides on-demand, actionable monitoring data and analytics for Holter, Event and mobile cardiac telemetry (MCT) directly to physicians. The company is led by Nancy Briefs, President, CEO and Co-Founder. InfoBionic raised a financing round to support commercialization of the MoMe® Kardia system. The articles report the company is based in Lowell, Massachusetts. InfoBionic is an emerging digital health company focused on providing anywhere, anytime access to cardiac event monitoring with improved event detection and clinical efficacy through a lower-cost business model. Its lead product, the MoMe System, is a cloud-based, multi-pass analysis universal remote patient monitoring platform that provides seamless transition between Holter, Event, and Mobile Cardiac Telemetry monitoring modes in one device. MoMe Kardia is positioned to address the roughly $3B worldwide cardiac monitoring market by delivering enhanced analytics and on-demand access to patient data for diagnosis. Proceeds from the recently closed Series B tranche will enable commercialization of the MoMe System in Europe and the United States. The company emphasizes cloud technology to improve patient monitoring, diagnosis and treatment while reducing operating and healthcare costs. Safeguard Scientifics’ participation and board representation signal strategic support for commercialization and growth.

Participated · Series B · Dec 2016

Qstream provides sales acceleration software that helps large organizations drive revenue through science, data, and mobile technology. Led by CEO and co-founder Duncan Lennox and based in Burlington, MA, the company has offices in Boston, San Francisco, Dublin, and London. Qstream serves more than 300 global brands across technology, financial services, and pharmaceutical sectors, including LinkedIn, Mastercard, Sun Life Financial, Pfizer, and Bristol–Myers Squibb. The company closed a $15M Series B round led by Polaris Partners, bringing total funding to $23M. Existing backers Frontline Ventures, Launchpad Venture Group and Excel Venture Management participated, and Gary Swart of Polaris joined the board. Qstream intends to use the funds to expand into US and EMEA markets. Qstream offers a SaaS mobile enterprise application that manages the human side of sales acceleration, combining a neuroscientific approach developed at Harvard and validated in more than 20 clinical trials. The platform is available in 12 languages and is deployed at scale across mobile and desktop environments. Qstream’s customers include eight of the world’s top 10 pharmaceutical firms and multiple market leaders in technology, financial services and health care. Led by CEO and co-founder Duncan Lennox, the company plans to use the new funding to accelerate expansion into the estimated $2 billion predictive analytics sector. Financially, the company closed a second tranche of Series A financing in January 2015, bringing total Series A commitments to $6.85M. Qstream offers a game-based, data-driven SaaS platform that delivers short, scenario-based daily challenges to sales reps on any device and uses game mechanics and analytics to drive engagement and coaching. The product is clinically proven to increase knowledge retention by up to 170% and lets managers measure team strengths in real time. Users typically spend about three minutes per day answering questions; Qstream has delivered more than 180 million questions in nine languages and has tens of thousands of registered users. Its customers include large life‑sciences, technology and financial-services brands such as Genentech, Boehringer Ingelheim, Intuitive Surgical, Oracle, SunGard, Rackspace and SunTrust. The company positions the platform for use cases like product launch support, competitive-threat management, and strategic business initiatives. Qstream plans to use the new funding to accelerate sales and marketing efforts in North America and Europe.

Participated · Series B · Nov 2016

Foodsmart operates a telenutrition and food benefits management platform that pairs virtual nutrition counseling from a network of U.S. Registered Dietitians with digital tools to plan personalized meals and order food. The platform enables patients to order from nationwide grocers and local medically tailored food partners, apply for SNAP benefits, and learn cost‑effective shopping strategies. Foodsmart partners with health plans and providers to support people facing chronic disease and food insecurity. The company serves over 2.2 million members through contracts with regional and national Medicaid managed care organizations, Medicare Advantage plans, commercial insurers, and more than 1,000 employers. Founded in 2010 and led by CEO Jason Langheier, Foodsmart is based in San Francisco, California. It intends to use the new funding to expand operations and broaden its business reach. Foodsmart (doing business as Zipongo) is a San Francisco-based personalized telenutrition and foodcare leader. The company offers a fully customizable app-based platform backed by a national network of Registered Dietitians that guides members through personalized journeys to healthier eating. Its platform integrates dietary assessments and nutrition counseling with online food ordering and cost-effective meal planning for whole families, making the most of ingredients at home and on the go. The company describes itself as the world's largest telenutrition and foodcare solution. Foodsmart emphasizes making healthy eating affordable and accessible, a mission highlighted by participation from social impact investors. Financially, the company announced a Series C funding round of more than $25 million. Zipongo, launched in 2014 by CEO Jason Langheier, MD, MPH, provides a Food Benefits Management (FBM) platform that delivers sustained engagement through tools including Health (Digital Dietitian), Cooking (recipes, meal planning, grocery delivery, and discounts) and Restaurants (menus, restaurant ordering, and workplace cafes). The company uses those tools to help people assess and improve their nutrition and engage with food-related benefits. It raised $18M in Series B1 financing to expand the platform beyond wellness toward using food as a first-line therapy to treat chronic disease. Zipongo is developing a new solution called FoodScripts to enable health plans and providers to use food to treat conditions. FoodScripts adds prescriptive, personalized, evidence-based modules addressing hypertension, diabetes, obesity and more. The company plans to roll out an early version of FoodScripts to pilot customers in the early spring. Zipongo provides a software-as-a-service platform that enables digital nutrition coaching for large employers, health plans and health systems, and offers food utility tools for families to select and buy healthy food. Its product suite includes meal planning, recipes, grocery rewards, online grocery ordering, menu coaching and mobile meal ordering for cooking and eating prepared meals. The company serves over 150 companies and the majority of national health plans and wellness platforms. Founded by Jason Langheier, MD, MPH, Zipongo combines coaching and commerce to drive healthier food choices. It has raised $28M in total funding and intends to use the new proceeds to expand operations. The platform targets enterprise and consumer-facing partners to broaden adoption. Zipongo offers a web-based health community and an iPhone app that deliver personalized wellness plans, recipes, and grocery deals. The platform personalizes recommendations by allowing users to opt in and connect electronic medical records via a HIPAA‑secure portal. It integrates loyalty-card discounts at local retailers and is building a digital partner network so users can redeem discounts at their preferred grocery stores. The product focuses on transaction-level support to help families identify and afford healthy options at the point of purchase. Zipongo was in private beta and preparing for a full-scale launch while developing technology to sync shopping history and health data automatically. The team recruited grocery and health-industry veterans as advisers to facilitate integration with national chains.